L3VLUP
ProSign in

ALC · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ALCLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ALC
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterALCLLY
Q3 202012 holders, $2.5bn33 holders, $14.1bn
Q4 202011 holders, $2.1bn29 holders, $17.3bn
Q1 202113 holders, $2.2bn24 holders, $23.0bn
Q2 20218 holders, $1.7bn24 holders, $27.8bn
Q3 20217 holders, $2.2bn31 holders, $29.9bn
Q4 20217 holders, $2.4bn31 holders, $34.7bn
Q1 20228 holders, $3.0bn24 holders, $35.3bn
Q2 20227 holders, $2.4bn33 holders, $42.7bn
Q3 202210 holders, $1.0bn31 holders, $43.4bn
Q4 202213 holders, $1.4bn31 holders, $46.6bn
Q1 202313 holders, $1.4bn33 holders, $44.3bn
Q2 202311 holders, $1.6bn37 holders, $59.6bn
Q3 202312 holders, $1.4bn44 holders, $67.6bn
Q4 202311 holders, $1.1bn45 holders, $73.6bn
Q1 20249 holders, $1.7bn41 holders, $95.3bn
Q2 20248 holders, $1.9bn43 holders, $110bn
Q3 202410 holders, $2.5bn45 holders, $107bn
Q4 202410 holders, $2.4bn46 holders, $93.9bn
Q1 202518 holders, $3.3bn42 holders, $98.4bn
Q2 202511 holders, $2.9bn43 holders, $93.2bn
Q3 202512 holders, $2.2bn39 holders, $86.7bn
Q4 202512 holders, $1.7bn41 holders, $123bn
Q1 20269 holders, $1.3bn39 holders, $106bn
Q2 20268 holders, $1.0bn44 holders, $132bn
ALC

Alcon AG

Holders
18
Reported value
$3.3bn
Buyers
13
Sellers
5

Breadth +8 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
LLY

Eli Lilly & Co

Holders
42
Reported value
$98.4bn
Buyers
22
Sellers
22

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2025

Among the 46 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ALC (4)

Davidson Kempner Capital Management LP, ExodusPoint Capital Management LP, Rokos Capital Management LLP, Two Sigma Investments LP

Only LLY (28)

Acadian Asset Management LLC, AQR Capital Management LLC, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Egerton Capital UK LLP, Eisler Capital Management Ltd, Element Capital Management LLC, GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Lone Pine Capital LLC, MFS Investment Management, Millennium Management LLC, Polen Capital Management LLC, Renaissance Technologies LLC, Tiger Global Management LLC, Tudor Investment Corp, and 3 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →